Hello, everyone, and how are you today? The weekend, which we hope you enjoyed, is now officially over and that, of course, means the time has come to resume that daunting routine of meetings and deadlines and countless other things to do. We are no different, so we are coping by quaffing yet another cup of stimulation. We invite you to join us. And to help you along, we have assembled a few items of interest. Hope your day goes well and stay in touch...
Pfizer Ends Celebrex Study In Children Early (Dow Jones)
Boehringer Ingelheim Eyes Pfizer Animal Health Business (Economic Times)
Teva Seeks To Intervene In Plan B Lawsuit (Bloomberg News)
FTC May Not Block Express Scripts-Medco Deal (Wall Street Journal)
Pfizer And J&J Try To Revive Class Of Arthritis Drug (Associated Press)
North Carolina Town Rethinks Pfizer Tax Cuts After Layoffs (Sanford Herald)
Sri Lanka To Place Price Controls On Drugs (Lanka Business Online)
EDITOR'S NOTE: Please check this post for updates throughout the morning
Coffee pix thx to chichcacha flickr creative commons